Treatment Regimen for Patients With ALK+ Non-Small Cell Lung Cancer

Treatment Regimen for Patients With ALK+ Non-Small Cell Lung Cancer

EP. 1: Case Presentation: Patient With ALK+ NSCLC

July 5th 2018

EP. 2: NSCLC: Initial Impressions and Alternate ALK Therapy

July 5th 2018

EP. 3: Typical Response, Progression, and Second-Line Therapy for NSCLC

July 5th 2018

EP. 4: Value of Repeat Mutation Testing for ALK+ NSCLC

July 5th 2018

EP. 5: ALK+ NSCLC: Brigatinib Indication and ALTA Trial

July 5th 2018

EP. 6: ALK+ NSCLC: PFS and Activity in CNS, Dosing, & Toxicity

July 5th 2018

EP. 7: Use of Brigatinib in ALK+ NSCLC & Future

July 5th 2018

Advertisement

Advertisement